| # | Drug | Count |
|---|---|---|
| 0 | LUTETIUM LU 177 DOTATATE | 12 |
| 1 | EVEROLIMUS | 11 |
| 2 | OCTREOTIDE ACETATE | 10 |
| 3 | EVEROLIMUS TABLETS | 4 |
| 4 | LANREOTIDE ACETATE | 2 |
| 5 | BELIMUMAB | 1 |
| 6 | DURVALUMAB | 1 |
| 7 | HYDROMORPHONE HYDROCHLORIDE | 1 |
| 8 | LAMOTIRIGINE | 1 |
| 9 | LAMOTRIGINE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEGFILGRASTIM-JMDB | 1 | 0.0022 |
| 1 | LUTETIUM LU 177 DOTATATE | 12 | 0.0021 |
| 2 | OCTREOTIDE ACETATE | 10 | 0.0003 |
| 3 | LANREOTIDE ACETATE | 2 | 0.0003 |
| 4 | EVEROLIMUS TABLETS | 4 | 0.0002 |
| 5 | EVEROLIMUS | 11 | 0.0002 |
| 6 | PALONOSETRON HYDROCHLORIDE | 1 | 0.0002 |
| 7 | PEGFILGRASTIM | 1 | 0.0001 |
| 8 | DURVALUMAB | 1 | 0.0000 |
| 9 | BELIMUMAB | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 1 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 | 0.0000 |
| 2 | Kinase Inhibitor [EPC] | 11 | 0.0000 |
| 3 | Leukocyte Growth Factor [EPC] | 2 | 0.0000 |
| 4 | Mood Stabilizer [EPC] | 1 | 0.0000 |
| 5 | Anti-epileptic Agent [EPC] | 1 | 0.0000 |
| 6 | GLP-1 Receptor Agonist [EPC] | 2 | 0.0000 |